| Financial Year |
March 31 2023 |
| Monetary Funds |
549,295,109.61 |
| Held-for-trading Financial Assets |
203,334,136.99 |
| Notes Receivable |
-- |
| Accounts Receivable |
798,992,927.31 |
| Advances to Suppliers |
26,528,650.92 |
| Other Receivables |
109,596,632.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
106,604,143.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,967,185.76 |
| Total Current Assets |
1,810,474,436.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
108,805,186.27 |
| Investment Properties |
17,110,441.24 |
| Fixed Assetes |
168,294,057.49 |
| Under-construction Projects |
371,112,660.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,613,724.20 |
| R&D expenses |
-- |
| Goodwill |
292,080,463.12 |
| Long-Term Deferred and Prepaid Expenses |
11,337,618.22 |
| Deferred Income Tax Assets |
58,850,655.91 |
| Other Non-Current Assets |
57,019,309.82 |
| Sub-Total of Non-Current Assets |
1,197,707,999.37 |
| Total Assets |
3,008,182,436.26 |
| Short-Term Loans |
4,204,748.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
208,249,699.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,376,005.74 |
| Taxes Payable |
12,043,661.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,801,990.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,957,025.57 |
| Other Current Liabilities |
2,590,846.09 |
| Sub-Total of Current Liabilities |
495,554,651.50 |
| Long-term Loans |
89,640,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,615,536.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,045,214.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
126,869,001.73 |
| Total Liabilities |
622,423,653.23 |
| Paid-In Capital(Or Share Stock) |
613,239,300.00 |
| Capital Surplus |
622,082,271.29 |
| Surplus Reserve |
88,112,639.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
759,995,606.93 |
| Minority Stockholder's Interest |
302,635,254.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,083,123,528.94 |
| Owner's Equity（Stockholder's Equity） |
2,385,758,783.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,008,182,436.26 |
